The TrackWise On-Premises End Of Life: An Opportunity To Reimagine Quality, Not Just Replace A Platform

By Vinod Nela

The end of on-premises support for TrackWise is more than an IT upgrade. For pharma, biotech, and medical device teams, it is a rare chance to rethink how quality work gets done. Explore three common responses: Deferrers who delay, Migrators who move the same system to the cloud, and Reimaginers who rebuild for the future. See what an AI-driven approach looks like in practice. AI agents sort deviations by risk, speed up corrective actions, and keep teams ready for inspection, and a four-level maturity model helps you judge where you stand today. Use this guide to choose a path that does more than swap platforms- one that lowers your cost of quality and keeps you ahead of regulators.